Last update Feb. 9, 2022
The Caralluma are a genus of succulent species, cacti, of the apocynaceae family. Several of them are used in traditional medicine for the treatment of diabetes, inflammatory processes, leprosy, obesity and rheumatism (Adnan 2014, Dutt 2012). They contain pregnane glycosides, flavonoid glycosides and flavones. (Adnan 2014, Dutt 2012
Caralluma fimbriata is widely used in India as food and to reduce appetite. Anorexigenic and slimming properties are attributed to it, without proven scientific evidence. (Jayawardena 2021, Arora 2015)
Caralluma europaea, distributed in Morocco, Sicily and southeastern Spain, are traditionally attributed numerous medicinal properties (antidiabetic, anti-infectious, anti-inflammatory), pending scientific confirmation. (Ouassou 2021)
At the date of the last update we have not found published data on its excretion in breast milk.
There is very little published data on the therapeutic use of this plant, but it appears to be devoid of toxicity.
Given its wide traditional use and its lack of toxicity, moderate consumption would be compatible with breastfeeding.
Precautions when taking plant preparations (Anderson 2017, Powers 2015, Posadzki 2013, Efferth 2011, Kopec 1999, Hsu 1995):
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.